A detailed history of Nebula Research & Development LLC transactions in Insmed Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 18,636 shares of INSM stock, worth $1.38 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
18,636
Holding current value
$1.38 Million
% of portfolio
0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $1.16 Million - $1.47 Million
18,636 New
18,636 $1.36 Billion
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $553,438 - $750,458
27,867 New
27,867 $704 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.